ArTS Archivio della ricerca di Trieste

ZAMPIERI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.879
EU - Europa 5.105
AS - Asia 4.355
SA - Sud America 461
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 4
Totale 17.928
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.784
IT - Italia 1.895
SG - Singapore 1.480
CN - Cina 1.129
SE - Svezia 908
UA - Ucraina 547
VN - Vietnam 396
HK - Hong Kong 392
BR - Brasile 369
KR - Corea 343
PL - Polonia 273
FR - Francia 266
DE - Germania 238
FI - Finlandia 233
TR - Turchia 231
GB - Regno Unito 171
RU - Federazione Russa 157
IE - Irlanda 107
BG - Bulgaria 105
IN - India 85
NL - Olanda 70
CA - Canada 50
BD - Bangladesh 48
AR - Argentina 35
MA - Marocco 33
JP - Giappone 32
MY - Malesia 31
SA - Arabia Saudita 30
BE - Belgio 29
ZA - Sudafrica 25
MX - Messico 23
CH - Svizzera 20
SN - Senegal 19
EU - Europa 18
EC - Ecuador 17
IQ - Iraq 17
AT - Austria 16
ES - Italia 15
ID - Indonesia 14
IR - Iran 14
PK - Pakistan 14
PH - Filippine 11
CL - Cile 9
IL - Israele 9
PY - Paraguay 9
TW - Taiwan 9
AZ - Azerbaigian 8
CO - Colombia 8
NP - Nepal 8
RO - Romania 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
EG - Egitto 6
UY - Uruguay 6
DK - Danimarca 5
GR - Grecia 5
HR - Croazia 5
KE - Kenya 5
KZ - Kazakistan 5
OM - Oman 5
JO - Giordania 4
KG - Kirghizistan 4
LT - Lituania 4
LV - Lettonia 4
PA - Panama 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
BH - Bahrain 3
CR - Costa Rica 3
ET - Etiopia 3
GT - Guatemala 3
PE - Perù 3
VE - Venezuela 3
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
DZ - Algeria 2
HN - Honduras 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
GN - Guinea 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
Totale 17.915
Salva come PNG Salva come JPEG
Città #
Singapore 897
Woodbridge 854
Ann Arbor 804
Ashburn 648
Trieste 607
Chandler 511
Houston 486
Jacksonville 480
San Jose 441
Fairfield 406
Hong Kong 381
Seoul 334
Hefei 305
Beijing 299
Wilmington 287
Izmir 203
Princeton 189
Warsaw 175
Dallas 171
Boardman 165
Seattle 164
Dearborn 145
Ho Chi Minh City 130
Chicago 126
Columbus 124
Milan 123
Cambridge 120
Los Angeles 116
Dublin 106
Sofia 104
Lauterbourg 97
Zgierz 90
Hanoi 85
Rome 80
Helsinki 69
Buffalo 66
Moscow 66
The Dalles 66
New York 57
Santa Clara 55
Frankfurt am Main 42
São Paulo 34
Bremen 32
Grafing 30
Nanjing 30
Brussels 29
San Diego 29
Des Moines 27
Düsseldorf 27
Kunming 27
Tokyo 26
Casablanca 25
Munich 25
Naples 25
Catania 24
Da Nang 23
Messina 23
Shanghai 23
London 22
Council Bluffs 21
Redwood City 21
Verona 21
Orem 20
Phoenix 20
Turin 20
Chennai 19
Dakar 19
Norwalk 19
Washington 19
Guangzhou 18
Jinan 17
Toronto 17
Florence 16
Dammam 15
Atlanta 14
Cagliari 14
Mestre 14
Tianjin 14
Bern 13
Brooklyn 13
Falls Church 13
Johannesburg 13
Montreal 13
Rio de Janeiro 13
Denver 12
Falkenstein 12
Haiphong 12
New Delhi 12
Perugia 12
Zhengzhou 12
Brescia 11
Nanchang 11
Portsmouth 11
Vienna 11
Hải Dương 10
Manchester 10
Quito 10
Shenyang 10
Bologna 9
Genoa 9
Totale 11.745
Salva come PNG Salva come JPEG
Nome #
Manuale di analisi qualitativa. Con e-book 666
Analisi Farmaceutica Qualitativa 507
Antimycobacterial activity of new 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues. 346
Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations 316
A 3D-Pharmacophore Model for σ2 Receptors Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives 309
Improving selectivity preserving affinity: New piperidine-4-carboxamide derivatives as effective sigma-1-ligands 290
Stability of a novel Lidocaine, Adrenaline and Tetracaine sterile thermosensitive gel: A ready-to-use formulation 285
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 283
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach 266
Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives. 262
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach 257
Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents 255
Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands 254
Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands 250
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: preliminary data and computational analysis 248
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the σ1 binding site 246
Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment 235
Another Brick in the Wall. Validation of the σ1Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ1Ligands 231
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands 224
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma1 receptor ligand based on a series of benzo[d]oxazol-2(3H)-one derivatives 218
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation 218
Antimycobacterial activities of N1-[1-[3-aryl-1-(pyridin-2-,3-, or 4-yl)-3-oxo]propyl]-2-pyridinecarboxamidrazones. 203
Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives 201
Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor 196
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 191
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method 191
Synthesis and antifungal activity of (9/)-1-(5-aryl-3-pyridin-2-yl-4,5-dihydro-pyrazol-1-yl)-2-imidazol-1-yl-ethanone derivatives. 190
Antitubercular activity of a new pyridinecarboxamidrazone compound alone and in combination with reference drugs, by MRA and in a macrophage model. 185
Exploring new structures in the development of new sigma ligands 182
3D pharmacophore model of σ1 binding site based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives. 178
Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives 177
2-Aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds. Convetional heating in comparison with MW-assisted synthesis. 171
1-substituted-3-(o-aminoalkyl)-1H-indole derivatives as possible sigma ligands. 170
PEGylation of coenzyme Q10 and in vitro release studies 170
null 168
Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation 167
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. 162
Overview on σ1 receptor: a 3D homology model to solve a part of the enigma. 161
Design, synthesis and biological profile of new piperidine-4-carboxamide as effective sigma ligands 151
3-Piperidin-4-yl-methyl-3H-benzoxazol-2-one derivatives as sigma ligands. 151
"Sintesi ed attività antimicobatterica di derivati 2-piridincarbossamidrazonici di 1-[4-(1H-imidazol-1-il)fenil]-3-arilpropanonni." 147
Synthesis and antimycobacterial activity of 1,3,4-oxadiazol-2-one derivatives 144
Antitubercular activity of novel 3-(2-oxo-2-arylethylidene)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-ones derivatives 144
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2) 142
Benzoxazinones and correlated scaffolds linked to benzylamino moieties through a butylene spacer. New sigma receptor ligands 142
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 141
Synthesis and antimycobacterial activity of some 4H-1,2,4-triazin-5-one derivatives 140
Substituted benzylaminoalkylindoles with preference for the σ2 binding site 137
The sigma-enigma. A multistep homology modeling of sigma1 receptors 134
“Progettazione, sintesi e valutazione dell’attività antimicobatterica ed antifungina di nuovi derivati imidazolici e triazolici. Studio correlato di molecular modeling.” 132
Progettazione e sintesi di nuovi derivati bis-imidazolici ad attività antifungina ed antimicobatterica 132
Iron Bioavailability in the Extracellular Environment Is More Relevant Than the Intracellular One in Viability and Gene Expression: A Lesson from Oligodendroglioma Cells 131
SYNTHESIS, MOLECULAR MODELING AND EXPERIMENTALACTIVITY OF SOME NEW ACETAMIDE, BENZAMIDE ANDPHENYLMETHANONE DERIVATIVES AS SIGMA LIGANDS. 128
Enantioselective chromatography and absolute configuration of N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines: potential sigma1 ligands. 127
A new class of substituted benzo[d]oxazole-2(3H)-one derivatives as sigma1 ligands. 127
Molecular modeling in drug design. New chemicals with antibacterial, antitubercular and antifungal activity: synthesis and MIC evaluatiotn. Experimental and computational approach. 126
Synthesis and antimycobacterial activity of 5-aryl-1-isonicotynoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives. 125
Benzossazol-2-oni e benzotiazol-2-oni come possibili ligandi sigma. 125
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 124
Novel 1,4-Benzoxazin-3-One Derivatives as Potential Antitubercular Compounds Targeting MenB Enzyme 122
Hybridization approach to drug discovery inhibiting Mycobacterium tuberculosis. An overview 115
null 109
null 103
null 101
The sigma enigma. 3D homology modeling, computer-assisted drug design, 3D pharmacophore-guided docking, MM/PBSA scoring, in silico/in vitro alanine scanning mutagenesis, and functional assay to unveil the sigma-1 receptor hidden secrets. 98
null 93
null 91
New hybrid derivatives of 3,4-dihydroquinolin-2(1H)-one and 5-phenyl-1,3,4-oxadiazol-2(3H)-one scaffolds as sigma ligands 91
Synthesis, Biological Evaluation and Computational Studies of New Hydrazide Derivatives Containing 1,3,4-Oxadiazole as Antitubercular Agents 89
null 88
null 88
Synthesis, Antimycobacterial Activity, and Computational Insight of Novel 1,4‐Benzoxazin‐2‐one Derivatives as Promising Candidates against Multidrug‐Resistant Mycobacterium Tuberculosis 87
Studio correlato a molecular modeling del’attività antifungina di nuovi derivati imidazolici e triazolici del piridincarbossamidrazone. 86
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 85
New hybrid derivatives of 3,4-dihydroquinolin-2(1H)-one and 5-phenyl-1,3,4-oxadiazol-2(3H)-one scaffolds as sigma-2 ligands 83
null 82
null 81
null 81
null 81
null 80
null 79
null 79
null 79
null 78
Orienting the design and synthesis towards sigma-2 receptor subtype 78
null 77
Synthesis and antifungal activity of new substituted 2-(1H-Imidazol-1-yl)-N-benzyl-N-(3-phenylprop-2-en-1-yl)-acetamide derivatives. 77
null 75
null 75
null 74
Design, synthesis and in vitro evaluation of antimycobacterial and antifungal activities of new heterocyclic derivatives 74
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives. 74
null 73
null 73
null 72
null 72
null 71
“One-pot synthesis of a,b-unsatured caroxylic acids via tandem Wittig olefination-hydrolysis reaction under combined microwave and ultrasound irradiation”. 71
SAR evaluation of chiral naphtylorfines with antinociceptive activity. 71
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R) 71
Totale 15.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.921
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 0 0 148
2021/20221.350 31 101 89 230 23 109 105 57 159 120 75 251
2022/20231.981 141 195 127 236 188 323 21 156 223 223 103 45
2023/20241.083 71 58 98 78 144 102 136 179 27 37 91 62
2024/20252.051 40 56 99 194 194 266 118 129 265 214 207 269
2025/20265.300 448 309 535 542 420 528 711 200 616 760 220 11
Totale 18.368